Log in to save to my catalogue

Cyclometallated ruthenium catalyst enables late-stage directed arylation of pharmaceuticals

Cyclometallated ruthenium catalyst enables late-stage directed arylation of pharmaceuticals

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2058504651

Cyclometallated ruthenium catalyst enables late-stage directed arylation of pharmaceuticals

About this item

Full title

Cyclometallated ruthenium catalyst enables late-stage directed arylation of pharmaceuticals

Publisher

London: Nature Publishing Group UK

Journal title

Nature chemistry, 2018-07, Vol.10 (7), p.724-731

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Biaryls are ubiquitous core structures in drugs, agrochemicals and organic materials that have profoundly improved many aspects of our society. Although traditional cross-couplings have made practical the synthesis of many biaryls, C–H arylation represents a more attractive and cost-effective strategy for building these structural motifs. Furthermo...

Alternative Titles

Full title

Cyclometallated ruthenium catalyst enables late-stage directed arylation of pharmaceuticals

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2058504651

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2058504651

Other Identifiers

ISSN

1755-4330

E-ISSN

1755-4349

DOI

10.1038/s41557-018-0062-3

How to access this item